Rockefeller Capital Management
AGIO icon

Rockefeller Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Rockefeller Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$554K Buy
14,935
+60
+0.4% +$1.82K ﹤0.01% 2034
2026
Q1 		$503K Sell
14,875
-6,196
-29% -$176K ﹤0.01% 1972
2025
Q4 		$574K Buy
21,071
+5,033
+31% +$177K ﹤0.01% 1830
2025
Q3 		$644K Buy
+16,038
New +$603K ﹤0.01% 1643
2022
Q3 		– Sell
-118
Closed -$2K – 3844
2022
Q2 		$2K Buy
118
+21
+22% +$474 ﹤0.01% 3740
2022
Q1 		$2K Sell
97
-77
-44% -$2.35K ﹤0.01% 3573
2021
Q4 		$5K Buy
+174
New +$7K ﹤0.01% 3240
2021
Q2 		– Sell
-87
Closed -$4K – 3422
2021
Q1 		$4K Hold
87
– – ﹤0.01% 2939
2020
Q4 		$3K Hold
87
– – ﹤0.01% 2536
2020
Q3 		$3K Hold
87
– – ﹤0.01% 2315
2020
Q2 		$5K Hold
87
– – ﹤0.01% 2075
2020
Q1 		$3K Sell
87
-51
-37% -$2.36K ﹤0.01% 2068
2019
Q4 		$7K Buy
+138
New +$5.22K ﹤0.01% 1689
2019
Q2 		– Sell
-1,781
Closed -$120K – 1641
2019
Q1 		$120K Buy
1,781
+48
+3% +$2.8K ﹤0.01% 713
2018
Q4 		$80K Hold
1,733
– – ﹤0.01% 477
2018
Q3 		$134K Buy
+1,733
New +$139K ﹤0.01% 381

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Rockefeller Capital Management's AGIO Position: Q2 2026 in Review

Rockefeller Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 0.4% in Q2 2026, buying an estimated $1.82K and bringing the position to 14,935 shares worth $554K. The position accounts for ﹤0.01% of the portfolio, ranked #2034.

Rockefeller Capital Management first reported a position in AGIO in Q3 2018 and has held it in 16 quarters since. The position peaked at $644K in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Rockefeller Capital Management held 14,935 shares of Agios Pharmaceuticals worth $554K as of Q2 2026.
  • Rockefeller Capital Management bought 60 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.82K.
  • Agios Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2034 holding.
  • Rockefeller Capital Management first reported a position in Agios Pharmaceuticals in Q3 2018 and has held it in 16 quarters since.
  • Rockefeller Capital Management's Agios Pharmaceuticals position peaked at $644K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.